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coronary bypass had no functional viability (n  39).
HSPB1 expression and phosphorylation were inversely as-
sociated with relaxation in response to sodium nitroprus-
side (figure 1). Inhibiting HSPB1 phosphorylation by pre-
treatment with SB203580, a p38 MAPK inhibitor or a cell
permeant peptide inhibitor of MK2, MK2i, enhanced re-
laxation (p  0.05 figure 2). Rat aortic smooth muscle
contains low levels of HSPB1; when treated with recombi-
nant HSPB1 with a protein transduction domain allowing
cell entry (rPTDHSPB1) led to increased HSPB1 impair-
ing relaxation (figure 3).
Conclusions: Taken together, these studies support a
role for HSPB1 in impaired relaxation of smooth muscle.
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Objectives: Grafting of surgically transplanted arteries
and veins to the arterial circulation is common in cardio-
vascular practice. Venous grafts degenerate rapidly follow-
ing implantation with intimal hyperplasia playing an impor-
tant role. In contrast, arterial grafts have excellent patency
rates in the long-term and might be superior to vein grafts.
Here we describe arterial and venous grafting to the mouse
aorta.
Methods: A model for implantation of vascular grafts
was established by transfer of the vena cava from donor
animals to the abdominal aorta in recipients. Arterial graft-
ing was performed by transfer of the abdominal aorta from
donor mouse to the same site in recipients. Histology,
scanning electron microscopy and confocal microscopy
were used to study development of intimal hyperplasia and
structural changes following transfer. Intravital microscopy
was used to study interactions between leukocytes and graft
endothelium.
Results: At different time points postop, scanning elec-
tron microscopy revealed that venous graft endothelium suf-
fers structural injurywhereas arterial grafts showno changes in
endothelial integrity. By cross transfer of grafts fromTie2GFP
mice that carry fluorescent endothelial cells intoWTmice and
subsequent confocal microscopy we determined that degen-
erated endothelium in venous grafts are of amixed originwith
most cells coming from the grafts but with contribution from
arterial endothelium and/or circulating endothelial progeni-
tor cells. Intimal hyperplasia was well developed at 28 days.
Intravital microscopy showed rolling and recruitment of leu-kocytes in vein grafts at 28 days and no such interactions were
observed in arterial grafts.
Conclusions: We’ve developed a stable and reproduc-
ible mousemodel of vascular grafting.We show endothelial
injury, intimal hyperplasia and inflammatory recruitment of
leukocytes in vein grafts but not in arterial grafts. This
animal model will be used in future experiments studying
the roles of inflammation in the formation of intimal hyper-
plasia.
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Objectives: Infections of indwelling medical devices
remain a source of morbidity and mortality. We have been
investigating the use of thin film nickel titanium (TFN) as a
novel material to cover stents for a wide array of vascular
applications, and have demonstrated that a super hydro-
philic surface treatment prevents platelet adhesion and de-
creases bacterial adhesion. The current study aimed to
show that biofilm producing bacteria will be unlikely to
form biofilm on super hydrophilic TFN (S-TFN) and that
any bacterial adhesion can be more effectively treated with
therapeutic doses of antibiotics compared to commercially
available endograft materials.
Methods: TFN was created using a sputter deposition
technique to a uniform thickness of 5 microns. TFN then
underwent surface treatment to create a hydrophilic layer.
Bacterial studies were conducted using Staphylococcus
Epidermidis strain 35984, a well characterized biofilm pro-
ducing species. 1cm2 samples of Dacron, ePTFE, Un-
treated TFN and S-TFN were placed in 10ml tryptic soy
broth, inoculated with 107 bacteria, and incubated at 37oC
for 24 hours. Samples were then treated with therapeutic
doses of rifampin/vancomycin for 24 hours. SEM images
were taken both before and after treatment.
Results: SEM imaging studies demonstrated consistently
decreased bacterial adhesion on S-TFN compared to all sam-
ples with significantly less biofilm deposition. Treatment with
antibiotics for 24 hours demonstrated near clearance of bac-
teria on S-TFN with all other samples having evidence of
persistent biofilm.
Conclusions: We demonstrate that the surface proper-
ties of S-TFN, namely its negatively charged, super hydro-
philic, and ultra smooth surface reduce the likelihood of
bacterial adhesion and significantly reduce biofilm deposi-
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the S-TFN to be treated more effectively with antibiotics
compared to commercially available endograft materials.
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Objectives: Vascular interventional procedures often
lead to endothelial denudation exposing vascular smooth
muscle cells (SMCs) to fluid shear stress (FSS) exerted by
the flowing blood. Intimal hyperplasia has been previously
found to be influenced by Endothelin-1 (Et-1) through its
receptors A and B (Et (A)/Et (B)). This study aimed to
investigate the regulation of Et-1 and Et (A)/Et (B) by FSS
in SMCs.
Methods: Rat aortic SMCs were exposed to FSS (14
dynes/cm2, 24 h) and endothelin-associated gene expression
studied using microarrays. Cells were also were subjected to
low shear (5 dynes/cm2) or high shear (14 dynes/cm2) and
the expression of Et-1 and its receptors studiedwithRT-PCR.
Following balloon injury to the rat carotid artery, RNA was
isolated at 0-20 h after injury and expression of endothelin-
associated genes studied with microarray technology. 10 days
after injury, carotid arteries were studied by immunohisto-
chemistry (IHC) using an Et (B) receptor antibody.
Results: Array analysis showed a decrease of Et-1
mRNA with a signal log ratio (SLR) of5 (p 0.0025) in
FSS exposed SMCs in vitro. RT-PCR revealed an mRNA
quantity of 29.9% (p  0.001) and 13.3% (p  0.001) for
the low and high FSS group, respectively. Et (B) receptor
mRNA was upregulated by FSS in SMCs (SLR 4.4, p 
0.025). RT-PCR showed a consistent upregulation (p 
0.001) in the low- and high FSS groups, but no significant
dose-response effect (945.9% and 733.4% for the low- and
high FSS groups vs control, respectively). Et (A) receptor
expression was increased in the low FSS group (381.7%,
p  0.001) compared to control, but no increase was seen
in the high FSS group. Following rat carotid injury, Et (B)
receptor mRNA was upregulated at 5, 10 and 20 h by
388.3%, 495.4% and 141.9%, respectively (p 0.05). IHC
showed a prominent Et (B) receptor expression in adlumi-
nal SMCs exposed to FSS.
Conclusions: This data suggests that Et-1 and its
receptors are regulated by FSS in SMCs. Further studies of
the endothelin system in this context are warranted.Author Disclosures: J. Ekstrand: Nothing to disclose; U.
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Objectives: Edaravone (Radicut®, Mitsubishi Tanabe
Pharma Co., JAPAN), the first free-radical scavenger is
presently used for acute cerebral infarction patients. We
aimed to evaluate whether edaravone suppresses reperfu-
sion injury focusing onmitochondrial activity and glycogen
storage in the lower extremity muscles.
Methods: Male Lewis rats (508 35 gm) were admin-
istrated a preoperative intraperitoneal injection of edara-
vone (3.0 mg/kg, edaravone group, n  8) or the same
dose of saline (control group, n  8). Both common
femoral arteries were clamped for 5 hours, and then
declamped. The muscles of the bilateral lower extremities
were harvested after more 5 hours from the start of reper-
fusion. They were stained with cytochrome-c oxidant as
mitochondrial activity, and Periodic Acid Schiff (PAS) as
glycogen storage. The percentages of cytochrome-c
oxidant area and PAS area were measured and compared.
Results: The mean percentage of cytochrome-c oxi-
dant area in the edaravone group was significantly higher
than that in controls (13.3  1.2 % vs 0.8  0.1%, p 
0.01). Themean percentage of PAS area in the edaravone
group was also significantly higher than that in controls
(51.7  6.8 % vs 7.3  2.1%, p  0.001, Fig. attached).
Conclusions: Our results suggested that edaravone
might suppress reperfusion injury after leg ischemia by
keeping a high level of mitochondrial activity, resulted in
also a high level of glycogen storage in muscles.
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